EP 84: Mark Kotter, CEO, and Founder of bit.bio, on creating every cell type and kickstarting a cell therapy revolution
September 1st, 2022 | 34 mins 50 secs
bitbio, drugdiscovery, genetics, thegeneticspodcast
Doctors have been transplanting organs for decades, but can we transplant reprogrammed stem cells to rejuvenate the human body?
EP 83: Daphne Koller, Founder & CEO of Insitro - Integrating machine learning and biology at scale to reimagine drug discovery
August 11th, 2022 | 45 mins 10 secs
drugdiscovery, genetics, insitro, thegeneticspodcast
This week’s guest, Daphne Koller, is the Founder and CEO of Insitro - a company shifting the paradigm of new drug discovery using predictive models.